A new method to estimate parameters of the growth model for metastatic tumours

Abstract

PurposeKnowledge of natural tumour growth is valuable for understanding tumour biology, optimising screening programs, prognostication, optimal scheduling of chemotherapy, and assessing tumour spread. However, mathematical modelling in individuals is hampered by the limited data available. We aimed to develop a method to estimate parameters of the growth model and formation rate of metastases in individual patients.Materials and methodsData from one patient with liver metastases from a primary ileum carcinoid and one patient with lung metastases from a primary renal cell carcinoma were used to demonstrate this new method. Metastatic growth models were estimated by direct curve fitting, as well as with the new proposed method based on the relationship between tumour growth rate and tumour volume. The new model was derived from the Gompertzian growth model by eliminating the time factor (age of metastases), which made it possible to perform the calculations using data from all metastases in each patient. Finally, the formation time of each metastasis and, consecutively, the formation rate of metastases in each patient were estimated.ResultsWith limited measurements in clinical studies, fitting different growth curves was insufficient to estimate true tumour growth, even if patients were followed for several years. Growth of liver metastases was well described with a general growth model for all metastases. However, the lung metastases from renal cell carcinoma were better described by heterogeneous exponential growth with various growth rates.ConclusionAnalysis of the regression of tumour growth rate with the logarithm of tumour volume can be used to estimate parameters of the tumour growth model and metastasis formation rates, and therefore the number and size distribution of metastases in individuals.

Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model

“…Exponential and Gompertz mathematical models [32] were fit to the mean tumor volume data (overtime) of all mice using non-linear regression, and goodness-of-fit of the models was compared through the Akaike’s Information Criteria (AIC) values and the extra sum-of-squares F test. Specific growth rate (SGR) and doubling time (DT) were determined and given in the output of the fitting analysis.…”

Meeting the needs of breast cancer: A nucleolin’s perspective

“…Exponential and Gompertz mathematical models 410 were fit to the mean tumor volume data (overtime) of all mice using non-linear regression, and the goodness-of-fit of the models was compared. The goodness-of-fit for each model was determined by the Akaike's Information Criteria (AIC) values and the extra sum-of-squares F test.…”

Towards Quantitative Imaging Biomarkers of Tumor Dissemination: a Multi-scale Parametric Modeling of Multiple Myeloma

“…In the original paper, the IKS model was validated on one single patient with a metastatic hepatocellular carcinoma (Iwata et al, 2000) and has been further tested on one other patient with liver cancer and one with lung cancer in Ref. (Mehrara et al, 2013). A few population studies have been carried out on mice populations with orthotoptic cell implantation (Hartung et al, 2014;Baratchart et al, 2015) (Benzekry et al, 2016), the observed dissemination dynamics also showing an overall good agreement with the IKS model, although Ref.…”